Epidemiology of cognitive syndromes in stroke: an update for clinicians

Dr Quinn discusses epidemiologic and clinical aspects of dementia and delirium in stroke survivors, and reviews data on this topic.

Dr Quinn has listed that he is/was a consultant/advisor for Novo Nordisk A/S and that he is/was a research grant recipient from the Bristol-Myers Squibb-Pfizer Alliance.